Current Strategies and Future Directions for Eluding Adenoviral Vector ImmunityDinesh S. Bangari(Sanofi (United States)), Suresh K. Mittal(Purdue University West Lafayette)Current Gene TherapyMarch 28, 200610.2174/156652306776359478Cited by 154SaveCiteExport RISWatch citationsRelated PapersImpact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine|PLoS ONE|2012|78Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness|PLoS ONE|2013|51